This intensive workshop explores the limitations of monolithic obesity treatments by shifting the focus from simple appetite suppression to the functional genomics and proteomics of energy expenditure. By examining the mechanistic drivers of thermogenesis and the evolving role of the adipocyte, participants will discover how to bypass the limitations of current standards of care and address critical clinical challenges, such as the deterioration of metabolic health and muscle atrophy associated with rapid weight loss.

This session will cover:

• Balancing the Two Levers of Weight Loss & Comparative Bioenergetics: Shifting the therapeutic paradigm from solely restricting energy intake to safely maximizing energy expenditure through novel thermogenic pathways.
• Overcoming the "Lean-Mass Trap" and the Muscle Problem: Addressing the critical challenge of muscle atrophy by prioritizing the preservation and enhancement of lean muscle mass alongside fat-selective reduction.
• Targeting the Adipocyte, Beiging, & UCP1-Independent Thermogenesis: Decoding phenotypic switching and alternative cellular energy expenditure mechanisms beyond traditional UCP1 pathways.
• Leveraging Functional Genomics, Proteomics, & Batokines: Utilizing high-resolution molecular data and batokine biomarker read-outs to identify novel targets, culminating in a Case Study on translating these insights into highly targeted therapeutic assets.